Eczema and Psoriasis: Managing Chronic Skin Conditions (2026)

Chronic skin conditions like eczema and psoriasis affect hundreds of millions of people worldwide — and profoundly impact quality of life, sleep, mental health, and self-confidence. Both are commonly confused with each other (and with other skin conditions), yet they have fundamentally different causes, mechanisms, and optimal treatments. Understanding which condition you have is the essential first step to managing it well.

Eczema (Atopic Dermatitis): What It Is

Eczema — the most common form being atopic dermatitis (AD) — affects an estimated 223 million people globally. It's the most common chronic inflammatory skin disease, particularly prevalent in children (affecting 10–20% of children in developed countries) though many carry it into adulthood and some develop it for the first time as adults.

Eczema is fundamentally a disease of the skin barrier. A defect in filaggrin — a protein essential for maintaining the skin's protective barrier — allows irritants, allergens, and microbes to penetrate the skin and trigger an immune response. This is why eczema often co-occurs with allergic rhinitis and asthma — it's part of the "atopic march," where the same immune dysregulation manifests in different organs at different ages.

Eczema Symptoms

• Intensely itchy, inflamed skin — the itch is often the most debilitating feature
• Dry, sensitive skin that easily becomes irritated
• Red to brownish-gray patches (lighter in darker skin, the appearance can differ significantly)
• Small, raised bumps that may weep fluid when scratched
• Thickened, cracked, or scaly skin from chronic scratching (lichenification)
• Typically affects the inner elbows, behind the knees, neck, wrists, and ankles in adults; cheeks and extensor surfaces in infants
• Symptom pattern: flares (acute worsening) and remissions

Psoriasis: What It Is

Psoriasis is an immune-mediated inflammatory disease that primarily affects the skin but can also involve joints (psoriatic arthritis, affecting 30% of psoriasis patients). It affects roughly 125 million people worldwide — about 2–3% of the global population.

In psoriasis, an overactive immune system (primarily T-cells) triggers rapid skin cell turnover — normally skin cells complete their lifecycle in about 28 days; in psoriasis this is compressed to 3–4 days. Skin cells accumulate faster than they can be shed, forming the characteristic thick, scaly plaques.

Psoriasis Symptoms

• Well-defined, raised, red plaques covered with silvery-white scales
• Commonly affects elbows, knees, lower back, and scalp
• Nails often show pitting, ridging, or separation from the nail bed
• Itching (less severe than eczema) and sometimes burning or soreness
• Auspitz sign — pinpoint bleeding when scales are removed
• Koebner phenomenon — psoriasis appearing at sites of skin injury or trauma

Key Differences Between Eczema and Psoriasis

Common Triggers and How to Manage Them

For Eczema

Skin irritants: Soap, detergents, shampoos, cleaning products, wool clothing, sweat, and fragrances commonly trigger eczema. Use fragrance-free, pH-balanced cleansers. Wear cotton against the skin. Use fragrance-free laundry detergent. Rinse thoroughly after swimming (chlorine is a major irritant).

Allergens: Dust mites, pet dander, pollen, and mold — particularly relevant for those with concurrent allergies. House dust mite reduction measures (allergen-proof covers, hot washing of bedding) benefit many eczema patients. Allergy testing can identify specific sensitivities.

Food: In some children with moderate-to-severe eczema, food allergies (particularly cow's milk, egg, peanut, wheat, soy, and fish) contribute to flares. Food allergy as an eczema trigger is more common in younger children than adults. Only avoid foods if allergy testing confirms a specific trigger — unnecessary food restriction causes nutritional problems.

Stress: Psychological stress consistently worsens eczema — it's not psychosomatic, it's neuroinflammatory. Stress management through mindfulness, exercise, and sleep improvement genuinely helps.

Temperature and humidity: Hot, sweaty conditions worsen eczema for many people. Air conditioning, loose cotton clothing, and avoiding overheating help. Cold, dry winter air also triggers flares — indoor heating reduces humidity, worsening skin dryness.

For Psoriasis

Infections: Particularly streptococcal throat infections trigger guttate psoriasis (small drop-shaped lesions) and can worsen plaque psoriasis. Prompt treatment of strep throat and other infections reduces psoriasis impact.

Medications: Beta-blockers, lithium, antimalarials (chloroquine), NSAIDs, and abrupt withdrawal of oral corticosteroids can trigger or worsen psoriasis. Discuss alternatives with your doctor if you suspect a medication connection.

Alcohol: Heavy alcohol consumption worsens psoriasis and reduces treatment response. This appears to be both a direct inflammatory effect and an indirect effect through reducing treatment efficacy.

Stress: As with eczema, psychological stress reliably triggers psoriasis flares through neuroimmune pathways.

Smoking: Smoking significantly worsens psoriasis severity and is associated with a specific subtype (palmoplantar pustulosis). Quitting improves outcomes.

Treatment: Eczema

Moisturization — The Foundation

Restoring and maintaining the skin barrier is the cornerstone of eczema management. Apply a thick, fragrance-free emollient (moisturizer) immediately after bathing — within 3 minutes while skin is still damp — to trap moisture. Use emollients liberally and frequently throughout the day. Creams and ointments are more effective than lotions. "Soak and seal" method: 10-minute lukewarm bath followed by immediate application of emollient and, if prescribed, topical medication.

Topical Corticosteroids

The mainstay of eczema treatment for decades — highly effective at reducing inflammation and itch during flares. Strength (potency) is matched to the severity and location of eczema: mild (hydrocortisone 1%) for the face and skin folds; moderate to potent for body. Concerns about steroid side effects (skin thinning) are real with prolonged use of potent preparations, but when used correctly for acute flares, they're safe and highly effective. Avoid using more than 2 weeks continuously on any area.

Topical Calcineurin Inhibitors (TCIs)

Tacrolimus (Protopic) and pimecrolimus (Elidel) — non-steroidal alternatives particularly useful for the face, eyelids, and skin folds where steroids carry higher risk. They don't cause skin thinning and can be used for longer periods. An FDA black box warning exists regarding theoretical cancer risk — this has not been confirmed in over 20 years of post-marketing surveillance and clinical use, and current evidence considers them safe.

Dupilumab (Dupixent) — A Breakthrough for Moderate-to-Severe Eczema

Approved in 2017, dupilumab is a biologic (monoclonal antibody) that blocks IL-4 and IL-13 — the key cytokines driving type 2 inflammation in eczema. It produces dramatic, sustained improvement in many patients with moderate-to-severe eczema who haven't responded adequately to topical treatments. Given by subcutaneous injection every 2 weeks. The most common side effect is conjunctivitis (eye inflammation) — manageable with eye drops. Dupilumab also treats asthma and nasal polyps, reflecting the shared inflammatory pathway.

Newer Biologic and Small Molecule Options (2025–2026)

• Tralokinumab (Adbry) — anti-IL-13; approved 2021
• Lebrikizumab (Ebglyss) — anti-IL-13; approved 2023
• JAK inhibitors (abrocitinib/Cibinqo, upadacitinib/Rinvoq) — oral daily pills; rapid onset (days vs weeks for biologics); significant risk-benefit discussion needed

Treatment: Psoriasis

Topical Treatments (Mild-Moderate)

Topical corticosteroids — first-line for most plaque psoriasis. Often combined with vitamin D analogues (calcipotriol/calcipotriene) — combination products (Taclonex, Enstilar) are more effective than either alone. Calcipotriol-betamethasone foam (Enstilar) is particularly effective for scalp and body psoriasis.

Coal tar — an older treatment with anti-inflammatory and anti-proliferative effects. Messy and smells bad, but effective for scalp psoriasis and as an add-on. Available in shampoos (T/Gel) and creams.

Phototherapy

Narrowband UVB (NB-UVB) phototherapy is highly effective for widespread plaque psoriasis — clearing or near-clearing in 60–70% of patients. Administered 3 times weekly in dermatology offices, or through home phototherapy units (prescription required). PUVA (psoralen + UVA) is an older form with higher skin cancer risk — less commonly used now.

Systemic Treatments (Moderate-Severe)

Methotrexate — weekly oral or injected; effective and inexpensive. Requires liver monitoring and folic acid supplementation. Contraindicated in pregnancy.

Cyclosporine — rapid onset; useful for severe flares. Limited to short-term use due to kidney and blood pressure effects.

Acitretin — a retinoid (vitamin A derivative); particularly effective for pustular and erythrodermic psoriasis. Highly teratogenic — must not be taken during or for 3 years after pregnancy.

Biologics — Transforming Psoriasis Treatment

Biologic therapies have revolutionized psoriasis treatment for moderate-to-severe disease. They produce skin clearance rates impossible with older systemic agents:

• IL-17 inhibitors (secukinumab/Cosentyx, ixekizumab/Taltz, bimekizumab/Bimzelx) — among the most effective; 90%+ skin clearance in many patients
• IL-23 inhibitors (guselkumab/Tremfya, risankizumab/Skyrizi, tildrakizumab) — excellent efficacy with quarterly or less frequent dosing
• TNF inhibitors (adalimumab/Humira, etanercept/Enbrel) — the original biologics; still effective, now often generic/biosimilar and more affordable

Deucravacitinib (Sotyktu) — approved 2022; a TYK2 inhibitor oral tablet with impressive efficacy and a favorable safety profile compared to JAK inhibitors.

The Mental Health Connection

Both eczema and psoriasis have profound impacts on mental health that are often undertreated. Depression affects 25–30% of people with psoriasis — roughly double the general population rate. Eczema's relentless itch and sleep disruption produce significant psychological distress. Visible skin conditions cause social anxiety, reduced self-esteem, and avoidance of activities.

Mental health support — CBT for chronic disease, mindfulness-based stress reduction, and treatment of depression when present — should be integrated into skin disease management. The relationship is bidirectional: psychological distress worsens skin disease, and better skin disease control improves mental health.

Frequently Asked Questions